The Role of Sirolimus in the Prevention of Cutaneous Squamous Cell Carcinoma in Organ Transplant Recipients

被引：0
|
作者：
Leblanc, Keith G., Jr. [1 ]
Hughes, Matthew P.
Sheehan, Daniel J. [1 ]
机构：
[1] Med Coll Georgia, Dermatol Sect, Augusta, GA 30904 USA
来源：
DERMATOLOGIC SURGERY | 2011年 / 37卷 / 06期
关键词：
NONMELANOMA SKIN-CANCER; CALCINEURIN INHIBITORS; CLINICAL-COURSE; RISK-FACTORS; PROGRESSION; IMMUNOSUPPRESSION; CONVERSION; EPIDEMIOLOGY; KIDNEY; GROWTH;
D O I：
10.1111/j.1524-4725.2011.01973.x
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
Skin cancers are common in organ transplant recipients (OTRs). In this review, we discuss the epidemiology of and risk factors for cutaneous neoplasms, particularly squamous cell carcinoma (SCC) in OTRs. The pathogenesis of SCC is reviewed, as well as the potential mechanisms for tumor progression and metastasis associated with two commonly used immunosuppressive medications: tacrolimus and cyclosporine. Finally, we discuss the mechanism of action and potential preventative use of sirolimus, a member of a newer class of immunosuppressants, the mammalian target of rapamycin inhibitors.
引用
收藏
页码：744 / 749
页数：6
相关论文
共 50 条
  • [1] Research gaps in the management and prevention of cutaneous squamous cell carcinoma in organ transplant recipients
    Blomberg, M.
    He, S. Y.
    Harwood, C.
    Arron, S. T.
    Demehri, S.
    Green, A.
    Asgari, M. M.
    BRITISH JOURNAL OF DERMATOLOGY, 2017, 177 (05) : 1225 - 1233
  • [2] Management of Cutaneous Squamous Cell Carcinoma in Organ Transplant Recipients
    Lowenstein S.E.
    Garrett G.L.
    He S.Y.
    Mansh M.
    Arron S.T.
    Current Dermatology Reports, 2015, 4 (4) : 159 - 167
  • [3] The pathogenesis of cutaneous squamous cell carcinoma in organ transplant recipients
    Harwood, C. A.
    Toland, A. E.
    Proby, C. M.
    Euvrard, S.
    Hofbauer, G. F. L.
    Tommasino, M.
    Bavinck, J. N. Bouwes
    BRITISH JOURNAL OF DERMATOLOGY, 2017, 177 (05) : 1217 - 1224
  • [4] Sirolimus use and risk of cutaneous squamous cell carcinoma (SCC) in solid organ transplant recipients (SOTRs)
    Asgari, Maryam M.
    Arron, Sarah T.
    Warton, E. Margaret
    Quesenberry, Charles P., Jr.
    Weisshaar, Dana
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 73 (03) : 444 - 450
  • [5] Comment on "Sirolimus use and risk of cutaneous squamous cell carcinoma (SCC) in solid organ transplant recipients (SOTRs)''
    Longo, Maria Isabel
    Wen, Xuerong
    Womer, Karl L.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : E105 - E106
  • [6] Response to "Comments on sirolimus use and risk of cutaneous squamous cell carcinoma (SCC) in solid organ transplant recipients"(SOTRs)
    Asgari, Maryam M.
    Arron, Sarah
    Warton, E. Margaret
    Quesenberry, Charles P.
    Weisshaar, Dana
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 86 (05) : E205 - E206
  • [7] Cutaneous oncology in organ transplant recipients: Meeting the challenge of squamous cell carcinoma
    Carucci, JA
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2004, 123 (05) : 809 - 816
  • [8] Cutaneous Squamous Cell Carcinomas in Organ Transplant Recipients
    Chockalingam, Ramya
    Downing, Christopher
    Tyring, Stephen K.
    JOURNAL OF CLINICAL MEDICINE, 2015, 4 (06): : 1229 - 1239
  • [9] Risk factors and prevention strategies for cutaneous squamous cell carcinoma in transplant recipients
    Urso, Brittany
    Kelsey, Andrew
    Bordelon, Jenna
    Sheiner, Patricia
    Finch, Justin
    Cohen, Joel L.
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2022, 61 (10) : 1218 - 1224
  • [10] The Tumor Immune Microenvironment in Cutaneous Squamous Cell Carcinoma Arising in Organ Transplant Recipients
    Zilberg, Catherine
    Lyons, James Guy
    Gupta, Ruta
    Ferguson, Angela
    Damian, Diona Lee
    ANNALS OF DERMATOLOGY, 2023, 35 (02) : 91 - 99
12345